38 related articles for article (PubMed ID: 35723676)
1. Improvement of vertigo symptoms and acoustic power absorbance in cases with endolymphatic hydrops.
Kobayashi M; Yoshida T; Fukunaga Y; Hara D; Sugimoto S; Naganawa S; Sone M
Laryngoscope Investig Otolaryngol; 2024 Feb; 9(1):e1210. PubMed ID: 38362179
[TBL] [Abstract][Full Text] [Related]
2. [A case report of middle ear cholesteatoma complicated with labyrinthine fistulaand delayed endolymphatic hydrops].
Lin F; Wu Q; Zhang Y; Dai C
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Aug; 37(8):670-672. PubMed ID: 37551579
[No Abstract] [Full Text] [Related]
3. Efficiency of a novel middle ear pressure device for intractable definite Meniere's disease and delayed endolymphatic hydrops after certification by the public health insurance system in Japan.
Nakazato A; Takakura H; Do TA; Ueda N; Takeda N; Watanabe Y; Shojaku H
Acta Otolaryngol; 2022 May; 142(5):388-394. PubMed ID: 35544580
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of middle ear pressure therapy with the EFET01 device in patients with Ménière's disease and delayed endolymphatic hydrops in Japan.
Tram Anh D; Takakura H; Nakazato A; Morita Y; Shojaku H
Acta Otolaryngol; 2023 Oct; 143(10):840-844. PubMed ID: 37995205
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of changes in endolymphatic volume after middle ear pressure therapy for intractable meniere's disease using 3D magnetic resonance imaging.
Kitahara T; Sakagami M; Inui H; Irino H
Acta Otolaryngol; 2023 Apr; 143(4):289-295. PubMed ID: 37067367
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of transtympanic intermittent pressure therapy using a tympanic membrane massage device for intractable meniere's disease and delayed endolymphatic hydrops.
Shojaku H; Takakura H; Asai M; Fujisaka M; Ueda N; Do TA; Tsubota M; Watanabe Y
Acta Otolaryngol; 2021 Nov; 141(11):977-983. PubMed ID: 34689678
[TBL] [Abstract][Full Text] [Related]
7. Effects of transtympanic intermittent pressure therapy using a new tympanic membrane massage device for intractable Meniere's disease and delayed endolymphatic hydrops: a prospective study.
Shojaku H; Aoki M; Takakura H; Fujisaka M; Asai M; Tsubota M; Ito Y; Watanabe Y
Acta Otolaryngol; 2021 Oct; 141(10):907-914. PubMed ID: 34520288
[TBL] [Abstract][Full Text] [Related]
8. 12-month effect of middle ear pressure therapy with the EFET01 device for intractable definite Meniere's disease and delayed endolymphatic hydrops after certification by the public health insurance system in Japan.
Nakazato A; Takakura H; Ueda N; Do TA; Takeda N; Watanabe Y; Shojaku H
Acta Otolaryngol; 2022 Jun; 142(6):491-498. PubMed ID: 35723676
[TBL] [Abstract][Full Text] [Related]
9. [Delayed endolymphatic hydrops].
Giannoni B; Pagnini P; Vannucchi P
Acta Otorhinolaryngol Ital; 1998 Aug; 18(4 Suppl 59):66-70. PubMed ID: 10205936
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and therapeutic strategies for Meniere's disease of the Japan Society for Equilibrium Research.
Iwasaki S; Shojaku H; Murofushi T; Seo T; Kitahara T; Origasa H; Watanabe Y; Suzuki M; Takeda N;
Auris Nasus Larynx; 2021 Feb; 48(1):15-22. PubMed ID: 33131962
[TBL] [Abstract][Full Text] [Related]
11. Visualization of endolymphatic hydrops with MR imaging in patients with Ménière's disease and related pathologies: current status of its methods and clinical significance.
Naganawa S; Nakashima T
Jpn J Radiol; 2014 Apr; 32(4):191-204. PubMed ID: 24500139
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
